- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MP-23-0034775

Oxydrug Pharmaceutical Private Limited
About Oxydrug Pharmaceutical Private Limited
Data last updated:
Oxydrug Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2021PTC055008. Its GSTIN is 23AADCO4011B1ZC (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Gupta and Rahul Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 177 Nx Shri Vinayak Town Sheep, Indore, Madhya Pradesh, India – 452020.
As per the financials filed for FY 2025, the company reported a revenue of ₹33,258, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹6,765 (net margin -20.3%) and EBITDA of -₹6,765 (EBITDA margin -20.3%).
Oxydrug Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0034775).
Company details
Recognitions & Rankings of Oxydrug Pharmaceutical
Contact details
Oxydrug Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address177 Nx Shri Vinayak Town Sheep, Indore, Madhya Pradesh, India – 452020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Oxydrug Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxydrug Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Oxydrug Pharmaceutical Private Limited, buy the company report.
Financials of Oxydrug Pharmaceutical Private Limited
FY 2024 filings availableOxydrug Pharmaceutical Private Limited reported revenue of ₹33,258 (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,765 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6,765 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -20.3% | ||||
| Net Profit Margin | -20.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oxydrug Pharmaceutical Private Limited, buy the company report.
Board of directors of Oxydrug Pharmaceutical Private Limited
Oxydrug Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Gupta | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Rahul Jaiswal | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Oxydrug Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Galaxy Diagnostics Private Limited | ₹33,621 (FY 2017) | 3869.0% | Uttar Pradesh, India | |||
| Satik Pharmaceuticals Private Limited | ₹33,620 (FY 2022) | Noida, Uttar Pradesh, India | ||||
| Evewen Corporate Solutions Private Limited | ₹33,542 (FY 2024) | -94.0% | Ernakulam, Kerala, India | |||
| Sunandini Charitable Foundation | ₹33,494 (FY 2019) | 4.0% | Greater Noida, Uttar Pradesh, India | |||
| Dhathri Ayurveda Hospitals and Researches Private Limited | ₹33,300 (FY 2025) | Ernakulam, Kerala, India | ||||
| Oxydrug Pharmaceutical Private Limitedthis company | ₹33,258 (FY 2025) | -₹6,765 | -20.3% | -30.0% | Indore, Madhya Pradesh, India | |
| Aptum Health Services Private Limited | ₹33,057 (FY 2023) | 45.0% | Bangalore, Karnataka, India | |||
| Wincrust Moneycare Nidhi Limited | ₹32,850 (FY 2025) | Delhi, India | ||||
| Bhumiputra Healthcare Private Limited | ₹32,829 (FY 2023) | Koochbehar, West Bengal, India | ||||
| Sri Venkateshwara Govinda Mala Deeksha Foundation | ₹32,811 (FY 2022) | Jeedimetla, Telangana, India | ||||
| Salutare Healthcare Private Limited | ₹32,600 (FY 2021) | -94.0% | Borivali, Mumbai, Maharashtra, India |
To see the full peer comparison of Oxydrug Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oxydrug Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxydrug Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oxydrug Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AADCO4011B1ZC | Madhya Pradesh | Active | 12 Feb 2022 |
To see the full GST registrations and return filing status of Oxydrug Pharmaceutical Private Limited, buy the company report.
Recent activity
Oxydrug Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manish Gupta was appointed as Director on 22 Feb 2021.
Frequently asked questions
Oxydrug Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 2021 (5+ years old) and is registered under CIN U51909MP2021PTC055008.
Oxydrug Pharmaceutical has 2 current directors:
- Manish Gupta - Director
- Rahul Jaiswal - Director
The latest financial statements of Oxydrug Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Oxydrug Pharmaceutical is 23AADCO4011B1ZC, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Oxydrug Pharmaceutical is U51909MP2021PTC055008. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxydrug Pharmaceutical was incorporated on 22 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Oxydrug Pharmaceutical by revenue are Galaxy Diagnostics Private Limited, Satik Pharmaceuticals Private Limited, Evewen Corporate Solutions Private Limited, Sunandini Charitable Foundation, Dhathri Ayurveda Hospitals and Researches Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Manish Gupta was appointed as Director on 22 Feb 2021. Rahul Jaiswal was appointed as Director on 22 Feb 2021.
Yes, Oxydrug Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0034775).
The registered office of Oxydrug Pharmaceutical is at 177 Nx Shri Vinayak Town Sheep, Indore, Madhya Pradesh, India – 452020.
Oxydrug Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

